Delivery Order SPE2DB20D7061-SPE2DB25FSPL0
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Methylergonovine 0.2 mg/mL injection vials, with a firm fixed price of $1,355.56 and an ultimate completion date of September 16, 2025. This non-competitive delivery order represents a single-transaction pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL in a one-milliliter volume on July 9, 2025, with a ceiling value of $4,786.56. This firm fixed-price delivery order, which completes on July 10, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,602.15 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract procures a pharmaceutical product used in obstetric care to prevent and treat postpartum...
- The Defense Logistics Agency awarded a $2,393.28 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,555.82 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,847.08 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.62 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, an ergot alkaloid medication used primarily in obstetric settings. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This delivery order, awarded September 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of methylergonovine 0.2 mg tablets in quantities of 28 units. The contract is valued at $7,605.24 with a firm fixed price structure and no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPL0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems by providing essential pharmaceutical products through the DLA's comprehensive global pharmaceutical support vehicle. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and gynecological settings, reflecting the broad therapeutic scope of products AmerisourceBergen delivers to federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/28/25 |